Venlafaxine is a drug used to treat depression. It is unrelated to other drugs used to treat depression.
Summary of
Interactions with Vitamins, Herbs, and Foods
(for details about the summarized interactions, read the full article)
|
5-Hydroxytryptophan (5-HTP)* L-tryptophan* St. John’s wort* |
|
|
Sodium |
|
| Depletion or interference |
None known |
| Side effect reduction/prevention |
None known |
| Supportive interaction |
None known |
| Reduced drug absorption/bioavailability |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
5-Hydroxytryptophan (5-HTP) and
L-tryptophan
Venlafaxine, a potent serotonin reuptake inhibitor, has been associated with several cases of
serotonin syndrome.1 2 3 4 5-HTP and L-tryptophan
are converted to serotonin in the brain, and taking them with venlafaxine may increase
venlafaxine-induced side effects. While no interactions with venlafaxine and 5-HTP or
L-tryptophan have been reported, until more is known, people taking venlafaxine are cautioned
to avoid 5-HTP or L-tryptophan.
Sodium
One case was reported of a 79-year-old woman with depression treated with venlafaxine who
experienced hyponatremia (abnormally low blood levels of sodium).5 It remains
unclear whether this interaction has any but rare ramifications.
St. John’s
wort (Hypericum perforatum)
Although there have been no interactions reported in the medical literature, it is best to
avoid using venlafaxine with St. John’s wort unless you are under the supervision of a
qualified healthcare professional.
Food
Venlafaxine is recommended to be taken with food.6
Alcohol
Venlafaxine may cause dizziness or drowsiness.7 Alcohol may intensify these effects
and increase the risk of accidental injury.8 To prevent problems, people taking
venlafaxine should avoid alcohol.
1. Brubacher JR, Hoffman RS, Lurin MJ. Serotonin syndrome from venlafaxine-tranylcypromine interaction. Vet Hum Toxicol 1996;38:358–61.
2. Weiner LA, Smythe M, Cisek J. Serotonin syndrome secondary to phenelzine-venlafaxine interaction. Pharmacotherapy 1998;18:399–403.
3. Bhatara VS, Magnus RD, Paul KL, Preskorn SH. Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms. Ann Pharmacother 1998;32:432–6.
4. Diamond S, Pepper BJ, Diamond ML, et al. Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports. Neurology 1998;51:274–6.
5. Ranieri P, Franzoni S, Rozzini R, Trabucchi M. Venlafaxine-induced reset osmostat syndrome: case of a 79-year-old depressed woman. J Geriatr Psychiatry Neurol 1997;10:75–8.
6. Threlkeld DS, ed. Central Nervous System Drugs, Antidepressants, Venlafaxine. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Mar 1995, 263r–3x.
7. Threlkeld DS, ed. Central Nervous System Drugs, Antidepressants, Venlafaxine. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Mar 1995, 263r–3x.
8. Threlkeld DS, ed. Central Nervous System Drugs, Antidepressants, Venlafaxine. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Mar 1995, 263r–3x.
Copyright © 2004 Healthnotes, Inc. All rights reserved. www.healthnotes.com
Please read the disclaimer about the limitations of the information provided here. Do NOT rely solely on the information in this article.
Learn more about Healthnotes, the company.
Learn more about the authors of Using Medicines with Vitamins and Herbs
The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires March 2005.